Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Interest & Investment Income: 2019-2025

Historic Interest & Investment Income for Benitec Biopharma (BNTC) over the last 5 years, with Jun 2025 value amounting to $1.0 million.

  • Benitec Biopharma's Interest & Investment Income rose 12.61% to $1.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $3.3 million, marking a year-over-year increase of 263.50%. This contributed to the annual value of $3.3 million for FY2025, which is 263.50% up from last year.
  • According to the latest figures from Q2 2025, Benitec Biopharma's Interest & Investment Income is $1.0 million, which was up 25.88% from $823,000 recorded in Q1 2025.
  • Over the past 5 years, Benitec Biopharma's Interest & Investment Income peaked at $1.0 million during Q2 2025, and registered a low of -$11,000 during Q4 2021.
  • Its 3-year average for Interest & Investment Income is $417,500, with a median of $300,000 in 2024.
  • In the last 5 years, Benitec Biopharma's Interest & Investment Income plummeted by 900.00% in 2022 and then skyrocketed by 20,675.00% in 2025.
  • Benitec Biopharma's Interest & Investment Income (Quarterly) stood at -$11,000 in 2021, then rose by 18.18% to -$9,000 in 2022, then skyrocketed by 33.33% to -$6,000 in 2023, then surged by 13,816.67% to $823,000 in 2024, then grew by 12.61% to $1.0 million in 2025.
  • Its last three reported values are $1.0 million in Q2 2025, $823,000 for Q1 2025, and $823,000 during Q4 2024.